Welcome to our dedicated page for Strive SEC filings (Ticker: ASST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Strive, Inc. filings document the company’s structured finance and asset management business, bitcoin treasury operations, preferred stock structure, and public-company governance. Its 8-K reports disclose business updates such as bitcoin, cash, investment and capital stock balances, dividend actions for the Variable Rate Series A Perpetual Preferred Stock, and quarterly operating and financial results.
Strive’s SEC record also includes proxy materials for annual meeting matters, including auditor ratification, and disclosures identifying the company as a Nevada corporation and emerging growth company. Filing subjects include Class A and Class B common stock, SATA preferred stock, advisory activities through Strive Asset Management, LLC, forward-looking risk language, and material-event reporting tied to capital allocation and treasury strategy.
Strive, Inc. Chief Executive Officer and director Matthew Ryan Cole reported an open-market purchase of 500,000 shares of Class A common stock on January 13, 2026. The filing states a volume-weighted average purchase price of $0.9187 per share, with individual trade prices ranging from $0.9111 to $0.9200 per share. Following this transaction, he directly holds 763,012 shares of Class A common stock.
The filing also lists indirect holdings of Class A shares: 366,709 shares held by LT&C LLC, where his spouse, as managing member, has sole voting and dispositive power and he disclaims beneficial ownership except for any pecuniary interest; 11,920 shares in his spouse’s IRA, also disclaimed except for pecuniary interest; and 58,739.194 shares held in his 401(k) plan account.
Strive, Inc. reported two key updates. From January 1–12, 2026, the company purchased approximately 123 bitcoin at an average price of about $91,561 per bitcoin, for a total of $11,264,000 including fees. After these purchases, Strive holds roughly 7,749.8 bitcoin, with a total acquisition cost of $874,258,244 and an average acquisition price of $112,810 per bitcoin, underscoring its large bitcoin treasury position.
Strive also announced that shareholders of Semler Scientific, Inc. approved Semler’s acquisition by Strive. The transaction is expected to close on or about January 16, 2026, subject to remaining conditions. The filing includes detailed cautionary language on Bitcoin volatility, integration risks, potential dilution from new Class A shares, and other uncertainties related to the proposed merger.
FMR LLC has filed an amended Schedule 13G reporting its beneficial ownership of 15,907,064 shares of Strive Inc Class A common stock, representing 2.7% of the class as of the event date. FMR is classified as a parent holding company, with sole voting and dispositive power over these shares.
Abigail P. Johnson is also listed as a reporting person with beneficial ownership of the same 15,907,064 shares, holding sole dispositive power but no voting power, and likewise reporting a 2.7% stake. The filing states the shares are held in the ordinary course of business and are not held for the purpose or effect of changing or influencing control of Strive Inc. It also notes that one or more other persons may receive dividends or sale proceeds, but no such person holds more than five percent of the outstanding Class A common stock.
Strive, Inc. has shared a communication related to its proposed business combination with Semler Scientific, Inc., emphasizing that many statements about the deal are forward-looking and subject to risks and uncertainties. The text explains that expectations about strategic and financial benefits, future performance, and timing of closing may differ materially from actual results and refers readers to recent Form 10-Qs and Strive’s Form S-4 for key risk factors.
Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the proposed transaction, which includes an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive sent to Semler Scientific stockholders to seek their approval. Investors and stockholders of Semler Scientific are urged to read the S-4 and related Information Statement/Proxy Statement/Prospectus and other SEC filings, which are available free of charge from the SEC’s website and the companies’ investor relations channels. The communication also identifies that directors, officers and employees of both companies may be deemed participants in the proxy solicitation and clarifies that this is not an offer or solicitation to buy or sell securities.
Strive, Inc. has shared a communication related to its proposed business combination with Semler Scientific, Inc., emphasizing that many statements about the deal are forward-looking and subject to risks and uncertainties. The text explains that expectations about strategic and financial benefits, future performance, and timing of closing may differ materially from actual results and refers readers to recent Form 10-Qs and Strive’s Form S-4 for key risk factors.
Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the proposed transaction, which includes an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive sent to Semler Scientific stockholders to seek their approval. Investors and stockholders of Semler Scientific are urged to read the S-4 and related Information Statement/Proxy Statement/Prospectus and other SEC filings, which are available free of charge from the SEC’s website and the companies’ investor relations channels. The communication also identifies that directors, officers and employees of both companies may be deemed participants in the proxy solicitation and clarifies that this is not an offer or solicitation to buy or sell securities.
Strive, Inc. has circulated a communication related to its proposed business combination with Semler Scientific, Inc.. The message emphasizes that it contains forward-looking statements about the strategic and financial effects of the planned transaction, the timing of closing and the integration of the two businesses, and warns that actual results may differ due to various risks and uncertainties.
Strive has filed a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in the transaction, which includes an information statement for Strive, a proxy statement for Semler Scientific and a prospectus for Strive. A definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders to seek their approval, and investors are urged to read these SEC materials, which also describe the interests and securities holdings of directors and executive officers involved in the proxy solicitation.
Strive, Inc. has circulated a communication related to its proposed business combination with Semler Scientific, Inc.. The message emphasizes that it contains forward-looking statements about the strategic and financial effects of the planned transaction, the timing of closing and the integration of the two businesses, and warns that actual results may differ due to various risks and uncertainties.
Strive has filed a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in the transaction, which includes an information statement for Strive, a proxy statement for Semler Scientific and a prospectus for Strive. A definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders to seek their approval, and investors are urged to read these SEC materials, which also describe the interests and securities holdings of directors and executive officers involved in the proxy solicitation.
Strive, Inc. and Semler Scientific, Inc. discuss their proposed merger and Bitcoin-focused strategy. Semler’s Eric Semler explains that the company adopted Bitcoin as its treasury asset and acquired over 5,000 Bitcoin in about a year, but its core medical business faced regulatory headwinds, prompting merger talks with Strive. He says Semler shareholders can now vote on the deal ahead of a special meeting on January 13, with both companies supporting approval.
Strive CEO Matt Cole outlines a combined strategy built around “digital credit” and perpetual preferred equity designed to provide amplified exposure to Bitcoin without traditional debt. He notes strong demand for Strive’s SATA preferred stock, including an upsized $200 million IPO that was more than two times oversubscribed and a current stated rate of 12.25% with an effective yield above 13%. The speakers also highlight potential upside from Semler’s healthcare operations, including a heart disease screening product that is awaiting FDA approval, while emphasizing that expectations about Bitcoin, digital credit growth, and regulatory outcomes are forward-looking and subject to risk.
Strive, Inc. and Semler Scientific, Inc. discuss their proposed merger and Bitcoin-focused strategy. Semler’s Eric Semler explains that the company adopted Bitcoin as its treasury asset and acquired over 5,000 Bitcoin in about a year, but its core medical business faced regulatory headwinds, prompting merger talks with Strive. He says Semler shareholders can now vote on the deal ahead of a special meeting on January 13, with both companies supporting approval.
Strive CEO Matt Cole outlines a combined strategy built around “digital credit” and perpetual preferred equity designed to provide amplified exposure to Bitcoin without traditional debt. He notes strong demand for Strive’s SATA preferred stock, including an upsized $200 million IPO that was more than two times oversubscribed and a current stated rate of 12.25% with an effective yield above 13%. The speakers also highlight potential upside from Semler’s healthcare operations, including a heart disease screening product that is awaiting FDA approval, while emphasizing that expectations about Bitcoin, digital credit growth, and regulatory outcomes are forward-looking and subject to risk.
Strive, Inc. filed a communication related to its proposed business combination with Semler Scientific, Inc.. The notice focuses on legal disclosures rather than deal terms, emphasizing that many statements about the transaction, its strategic and financial benefits, timing, and post-closing performance are "forward-looking statements" that involve significant risks and uncertainties. It explains that actual results for Strive, Semler Scientific, or the combined company may differ materially from these expectations.
The communication highlights that Strive has filed a Form S-4 registration statement to register Class A common stock to be issued in the deal, which includes an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive. Semler Scientific stockholders are urged to read the registration statement, the combined Information Statement/Proxy Statement/Prospectus, and related SEC filings before voting or making any investment decision. The document also explains that directors, officers, and employees of both companies may be considered participants in soliciting proxies and clarifies that this communication is not an offer or solicitation to buy or sell securities.
Strive, Inc. filed a communication related to its proposed business combination with Semler Scientific, Inc.. The notice focuses on legal disclosures rather than deal terms, emphasizing that many statements about the transaction, its strategic and financial benefits, timing, and post-closing performance are "forward-looking statements" that involve significant risks and uncertainties. It explains that actual results for Strive, Semler Scientific, or the combined company may differ materially from these expectations.
The communication highlights that Strive has filed a Form S-4 registration statement to register Class A common stock to be issued in the deal, which includes an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive. Semler Scientific stockholders are urged to read the registration statement, the combined Information Statement/Proxy Statement/Prospectus, and related SEC filings before voting or making any investment decision. The document also explains that directors, officers, and employees of both companies may be considered participants in soliciting proxies and clarifies that this communication is not an offer or solicitation to buy or sell securities.
Strive, Inc. and Semler Scientific are moving forward with a proposed business combination and related stockholder vote. Strive has filed a Registration Statement on Form S-4 with the SEC to register the Class A common stock it plans to issue in connection with the transaction, which includes an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive. A definitive Information Statement/Proxy Statement/Prospectus has been sent to Semler Scientific stockholders to seek their approval of the deal, and investors are urged to read these materials and any amendments because they contain important details about both companies and the transaction. The communication emphasizes that many statements are forward-looking and subject to significant risks and uncertainties, directs investors to SEC and company websites for free copies of relevant filings, explains that directors and officers of both companies may be participants in the proxy solicitation, and clarifies that this communication does not itself constitute an offer or solicitation to buy or sell securities.
Strive, Inc. and Semler Scientific are moving forward with a proposed business combination and related stockholder vote. Strive has filed a Registration Statement on Form S-4 with the SEC to register the Class A common stock it plans to issue in connection with the transaction, which includes an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive. A definitive Information Statement/Proxy Statement/Prospectus has been sent to Semler Scientific stockholders to seek their approval of the deal, and investors are urged to read these materials and any amendments because they contain important details about both companies and the transaction. The communication emphasizes that many statements are forward-looking and subject to significant risks and uncertainties, directs investors to SEC and company websites for free copies of relevant filings, explains that directors and officers of both companies may be participants in the proxy solicitation, and clarifies that this communication does not itself constitute an offer or solicitation to buy or sell securities.
Strive, Inc. released a communication about its proposed business combination with Semler Scientific, Inc., explaining that the message contains forward-looking statements about the deal, its expected strategic and financial benefits, integration, and timing, all of which are subject to significant risks and uncertainties. The companies refer investors to prior SEC filings, including Strive’s Form S-4 filed on December 3, 2025 and both parties’ recent Form 10-Qs, for additional risk factors. Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, which includes an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive that was sent to Semler Scientific stockholders to seek approval of the proposed transaction. The communication identifies that directors, officers, and employees of both companies may be deemed participants in the proxy solicitation, provides ways to access SEC filings and company materials free of charge, and clarifies that this message is not an offer to sell securities or a solicitation to buy securities or votes.
Strive, Inc. released a communication about its proposed business combination with Semler Scientific, Inc., explaining that the message contains forward-looking statements about the deal, its expected strategic and financial benefits, integration, and timing, all of which are subject to significant risks and uncertainties. The companies refer investors to prior SEC filings, including Strive’s Form S-4 filed on December 3, 2025 and both parties’ recent Form 10-Qs, for additional risk factors. Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, which includes an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive that was sent to Semler Scientific stockholders to seek approval of the proposed transaction. The communication identifies that directors, officers, and employees of both companies may be deemed participants in the proxy solicitation, provides ways to access SEC filings and company materials free of charge, and clarifies that this message is not an offer to sell securities or a solicitation to buy securities or votes.
Strive, Inc. describes its proposed business combination with Semler Scientific, Inc. and highlights that it has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in connection with the deal. The Form S-4 includes an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive, and a definitive version has been sent to Semler Scientific stockholders to seek their approval of the transaction.
The communication emphasizes that many statements about the expected benefits, timing, and integration of the combined company are forward-looking and subject to significant risks and uncertainties, directing readers to prior SEC filings for detailed risk factors. It explains how investors can obtain the S-4 and related documents free of charge from the SEC and company websites and notes that directors, officers, and employees of both companies may be deemed participants in the proxy solicitation. The message also clarifies that it does not constitute an offer to sell or buy securities.
Strive, Inc. describes its proposed business combination with Semler Scientific, Inc. and highlights that it has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in connection with the deal. The Form S-4 includes an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive, and a definitive version has been sent to Semler Scientific stockholders to seek their approval of the transaction.
The communication emphasizes that many statements about the expected benefits, timing, and integration of the combined company are forward-looking and subject to significant risks and uncertainties, directing readers to prior SEC filings for detailed risk factors. It explains how investors can obtain the S-4 and related documents free of charge from the SEC and company websites and notes that directors, officers, and employees of both companies may be deemed participants in the proxy solicitation. The message also clarifies that it does not constitute an offer to sell or buy securities.